Grant Funded Biotechnology Startups
The 50 entries shown cover grant awards to biotechnology companies logged between September 2 and October 26, 2022.
The 50 entries shown cover grant awards to biotechnology companies logged between September 2 and October 26, 2022. Disclosed amounts span from $30K (VoxCell BioInnovation, Victoria, British Columbia) to $173M (Allen Institute for Brain Science, Seattle), with that upper figure sitting well above the rest of the set. Eight entries carry undisclosed amounts, distributed across Canada, the UK, Switzerland, Denmark, and Israel.
US companies account for the majority of recipients, with New York appearing four times — Soterix Medical, EVQLV, RenBio, and Glyphic Biotechnologies. Canadian recipients include six companies spread across British Columbia, Ontario, Alberta, and Quebec; entries outside North America span Switzerland, the UK, Germany, Portugal, the Netherlands, Sweden, Denmark, Australia, and Israel. A cluster of awards falls in the $2M–$5M range; representative examples include IMMUNETHEP in Portugal and CND Life Sciences in Scottsdale (both $3M) and Adaptive Phage Therapeutics in Bethesda ($5M).
Most recent rounds
50 shownRelated listings
Frequently asked
What are the largest disclosed grants in this dataset?
The Allen Institute for Brain Science in Seattle received $173M, the largest by a significant margin. The next two are North Carolina Biotechnology Center at $25M and ImmuneSensor Therapeutics in Dallas at $16M. OraSure Technologies in Bethlehem, Pennsylvania received $10M and Day Zero Diagnostics in Boston received $8M.
Which cities appear most often among the grant recipients shown?
New York leads with four recipients — Soterix Medical, EVQLV, RenBio, and Glyphic Biotechnologies. Boston has two (Day Zero Diagnostics and Aldatu Biosciences), as does Madison, Wisconsin (Cellular Logistics and Cellectar Biosciences). No other city appears more than once in this dataset.
How many of these biotech companies are headquartered outside the US?
Eighteen of the 50 companies are based outside the US. Canada is the largest non-US cohort with six recipients — including Qu Biologics in Vancouver ($7M) and Treventis in Toronto ($3M) — followed by Switzerland with three (Evolva, MetrioPharm, BioLingus) and the UK with two (ZiO Health in London, LiberEat in Aberdeen). Single entries come from the Netherlands, Portugal, Germany, Israel, Sweden, Denmark, and Australia.
What does the grant size distribution look like when the two largest awards are excluded?
Removing the $173M Allen Institute for Brain Science and the $25M North Carolina Biotechnology Center grants, disclosed amounts mostly fall between $240K and $8M. The $2M and $3M marks are the most common — IMMUNETHEP, Treventis, RenBio, Aldatu Biosciences, and CND Life Sciences all received exactly $3M. The smallest disclosed grant is $30K to VoxCell BioInnovation in Victoria, British Columbia.
Which grants in this dataset have undisclosed amounts?
Eight of the 50 entries list undisclosed amounts: DC4U (Breukelen, Netherlands), ZiO Health (London), Adapsyn Bioscience (Hamilton, Ontario), Sapience Therapeutics (Scarsdale, New York), RevBio (Lowell, Massachusetts), BioLingus (Hergiswil, Switzerland), Azura Ophthalmics (Tel Aviv), and Evaxion Biotech (Copenhagen).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.